This predetermined meta-analysis focused on cardiovascular factors and included all seven randomized controlled trials from the tirzepatide T2D clinical development program, known as SURPASS, with a minimum duration of 26 weeks
Exploring GLP-1 Weight Loss Medications and Potential Side Effects Are you exploring lasting weight loss solutions
In just one relaxing treatment, your body is nourished with a baseline of healthy fluids that get rid of toxins and increase hydration
A Phase 2 study published in The New England Journal of Medicine (Jastreboff et al., 2023) reported substantial weight reduction in participants with obesity
Because the treatments (V, CS, C, S, WM, PF) were not distributed evenly among the experiments, experiment was not used as a covariate in the pooled analysis
Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information